Hyperuricemia predicts kidney disease progression after acute allograft dysfunction

Area of Science:

• Nephrology
• Transplantation Immunology
• Cardiovascular Medicine

Background:

• Hyperuricemia is linked to adverse outcomes, including cardiovascular events and chronic allograft nephropathy.
• Acute allograft dysfunction in kidney transplant recipients presents a risk for further kidney disease progression.

Purpose of the Study:

• To determine if hyperuricemia independently predicts kidney disease progression post-acute allograft dysfunction.
• To evaluate the association between serum uric acid levels and composite endpoints in kidney transplant recipients.

Main Methods:

• 124 kidney transplant recipients with acute allograft dysfunction were divided into hyperuricemic and normouricemic groups.
• Serum uric acid levels were averaged over three months prior to the study.
• Cox regression and Kaplan-Meier analyses assessed the impact of hyperuricemia on graft failure and creatinine doubling.

Main Results:

• Hyperuricemic patients showed significantly poorer cumulative survival and higher rates of creatinine doubling and graft failure (P = .025).
• Independent predictors of poor outcome included age at biopsy, hyperuricemia (HR, 2.24), and interstitial fibrosis and tubular atrophy (IF/TA).
• Hyperuricemia and IF/TA remained significant predictors after adjusting for other variables.

Conclusions:

• Persistently elevated serum uric acid levels are a significant contributor to kidney disease progression after acute allograft dysfunction.
• Interstitial fibrosis and tubular atrophy (IF/TA) also play a critical role in the risk of kidney disease progression.